期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (3)
Histopathological growth patterns (HGPs) of liver metastases represent a potential biomarker for prognosis after resection. They have never been studi......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (3)
Patients with peritoneal metastases (PM) of colorectal cancer have a very poor outcome. Intraperitoneal delivery of chemotherapy is the preferred rout......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (4)
Cetuximab, an epidermal growth factor receptor ( EGFR) inhibitor, is extensively used for clinical therapy in KRAS wildtype colorectal cancer (CRC) pa......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (3)
Brain metastases (BM) in patients with thyroid cancer (TC) are rare with an incidence of 1% for papillary and follicular, 3% for medullary and up to 1......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (6)
Diagnosing malignant pleural effusions (MPE) is challenging when patients lack a history of cancer and cytopathology does not detect malignant cells i......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (2)
BackgroundSufentanil combined with parecoxib sodium is a commonly used postoperative medication for cancer patients. However, the effects of this comb......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (4)
Liver metastasis is a frequent phenomenon in advanced tumor disease. Immune checkpoint inhibitors (ICIs) are a new class of therapeutics that can impr......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; ()
Introduction: The microarchitecture of liver metastases (LMs), or histopathological growth pattern (HGP), has been demonstrated to be a significant pr......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; ()
Ketogenic diets (KDs) can improve the well-being and quality of life of breast cancer patients. However, data on the effects of KDs on mammary tumors ......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (2)
Brain metastasis is the main cause of treatment failure and melanoma-related death. Inadequate concentrations of therapeutic drugs in the brain due to......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (4)
Clinical decision-making for patients with breast cancer (BC) is still primarily based on biomarker characteristics of the primary tumor, together wit......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (6)
The Graded Prognostic Assessment (GPA) score has the best accuracy among prognostic scales for patients with brain metastases (BM). A wide range of GP......
期刊： CLINICAL & EXPERIMENTAL METASTASIS, 2023; 40 (2)
While colorectal and gastroesophageal cancer represent the two gastrointestinal (GI) tumor entities with the highest incidence of brain metastatic (BM......
